T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
HealthStream
HSTM
$849M
| $598K | ﹤0.01% |
18,785
+1,550
| +9% | +$47.8K |
|
2202
Koppers
KOP
$857M
| $597K | ﹤0.01% |
18,422
+1,254
| +7% | +$44.8K |
|
2203
Bumble
BMBL
$359M
| $596K | ﹤0.01% |
73,204
-12,008
| -14% | -$92.7K |
|
2204
Xperi
XPER
$321M
| $596K | ﹤0.01% |
58,001
-8,608
| -13% | -$80.4K |
|
|
OSG
2205
Octave Specialty Group
OSG
$210M
| $593K | ﹤0.01% |
46,835
+7,042
| +18% | +$84.9K |
|
2206
Microvision
MVIS
$89.7M
| $592K | ﹤0.01% |
30,122
+1,208
| +4% | +$19K |
|
2207
Kforce
KFRC
$1.03B
| $591K | ﹤0.01% |
10,421
+1,072
| +11% | +$62.3K |
|
2208
Arcutis Biotherapeutics
ARQT
$3.3B
| $590K | ﹤0.01% |
42,349
-17,799
| -30% | -$195K |
|
2209
Sinclair Inc
SBGI
$1.03B
| $590K | ﹤0.01% |
36,500
+2,035
| +6% | +$34.3K |
|
2210
SES AI
SES
$227M
| $588K | ﹤0.01% |
268,402
+154,206
| +135% | +$87.9K |
|
2211
PetMed Express
PETS
$43.4M
| $587K | ﹤0.01% |
121,700
-8,400
| -6% | -$39.4K |
|
|
GEAR
2212
DELISTED
Revelyst, Inc.
GEAR
| $587K | ﹤0.01% |
+30,504
| New | +$581K |
|
2213
Vita Coco
COCO
$3.85B
| $584K | ﹤0.01% |
15,806
+2,860
| +22% | +$95.3K |
|
2214
Applied Digital
APLD
$8.81B
| $583K | ﹤0.01% |
76,250
+37,783
| +98% | +$314K |
|
2215
SITE Centers
SITC
$156M
| $583K | ﹤0.01% |
38,067
-139,348
| -79% | -$2.25M |
|
2216
CareDx
CDNA
$2.45B
| $581K | ﹤0.01% |
27,116
+3,016
| +13% | +$73.4K |
|
2217
Evolus
EOLS
$536M
| $581K | ﹤0.01% |
52,593
+6,332
| +14% | +$89K |
|
2218
Herbalife
HLF
$1.28B
| $578K | ﹤0.01% |
86,283
-8,072
| -9% | -$60K |
|
|
REFI
2219
Chicago Atlantic Real Estate Finance
REFI
$268M
| $578K | ﹤0.01% |
37,460
+4,454
| +13% | +$70.1K |
|
2220
Xeris Biopharma Holdings
XERS
$1.52B
| $578K | ﹤0.01% |
170,482
+9,506
| +6% | +$30.6K |
|
2221
Amer Sports
AS
$19.3B
| $576K | ﹤0.01% |
20,575
+5,020
| +32% | +$111K |
|
2222
Axogen
AXGN
$2.58B
| $574K | ﹤0.01% |
34,820
+3,220
| +10% | +$45.6K |
|
2223
Gevo
GEVO
$401M
| $573K | ﹤0.01% |
273,900
| – | – |
|
2224
MBIA
MBI
$254M
| $573K | ﹤0.01% |
88,558
+11,855
| +15% | +$61.1K |
|
2225
Beazer Homes USA
BZH
$874M
| $572K | ﹤0.01% |
20,807
+1,757
| +9% | +$56.1K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.